One year later, the same group published a study [35] aimed at identifying the role of maternal gut microflora as an indicator for the need for insulin in patients with GDM and determining the effect of insulin therapy on the composition of gut microflora in mothers with GDM and their neonates. The gene discussed is INS; the disease is gestational diabetes.